References in periodicals archive ?
According to studies, acinetobacter infections are not uncommon in preterm ICUs and there are reports of infant deaths in other countries.
Currently, the antimicrobials that can be utilized in some cases of Acinetobacter infection are sulbactam, carbapenems, aminoglycosides, tigecycline, and polymixin-based compounds (1, 4-6).
We found few Acinetobacter infections at the VAPAHCS, which may reflect the changing epidemiology of Acinetobacter infections in OIF/OEF veterans or successful treatment of Acinetobacter infection closer to the time of acquisition in Afghanistan or Iraq.
Less than 1% of the Acinetobacter infections came from hospitals with fewer than 200 beds, while 55% came from hospitals with more than 500 beds.
Mortality can be high for patients with Acinetobacter infections.
Antibiotic treatment of Acinetobacter infections should be based on the particular sensitivities of individual isolates, because the organism has developed resistance to multiple drugs, including members of the penicillin, aminoglycoside, fluoroquinolone, and cephalosporin families.
James' intensive care unit have kept the ionizers in operation since the clinical trial ended and continue to report fewer acinetobacter infections on the ward.
It also reviews key players involved in the therapeutic development for Acinetobacter Infections.
aeruginosa and MDR Acinetobacter infections, respectively, for which few treatment options remain available.
However, very limited clinical data are available to draw conclusion on the utility of tigecycline in treatment of MDR Acinetobacter infections.
Acinetobacter infections frequently occur in severely ill ICU patients with other chronic illnesses or prolonged hospitalizations.
Mortality can be high for patients who have Acinetobacter infections.